Skip to content

Construction and Study of an Artificial Intelligence-Based Early Diagnosis Model for Gallbladder Cancer

Construction and Study of an Artificial Intelligence-Based Early Diagnosis Model for Gallbladder Cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104280
Enrollment
Unknown
Registered
2025-06-13
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder Cancer, GBC

Interventions

Sponsors

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1.Patients with primary benign or malignant gallbladder diseases treated at multiple centers and confirmed by pathology. 2.Aged 18 to 74 years, with no gender restrictions. 3.Karnofsky Performance Score greater than 50.

Exclusion criteria

Exclusion criteria: 1.Simultaneous presence of two or more malignant tumors, or gallbladder malignant lesions that are not primary. 2.Combined with severe central nervous system diseases, respiratory diseases, autoimmune diseases, chronic renal insufficiency, long-term use of immunosuppressants, or severe uncontrolled infections. 3.Simultaneous presence of active cardiovascular or cerebrovascular diseases, including a history of stroke, myocardial infarction, or unstable angina within the past 6 months, or congestive heart failure classified as NYHA Class II or above, as well as severe arrhythmias requiring medical treatment. 4.Women of childbearing age with a positive blood pregnancy test or without a pregnancy test, as well as pregnant or breastfeeding women. 5.Patients who have participated in other therapeutic clinical trials with unclear treatment measures or unavailable treatment information during the course of their disease.

Design outcomes

Primary

MeasureTime frame
accuracy;sensitivity;specificity;

Countries

China

Contacts

Public ContactLi Maolan

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

limaolan6@163.com+86 21 58752345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026